Sinopharm Group Co. Ltd. (HKG:1099)
Hong Kong · Delayed Price · Currency is HKD 16.38
-0.46 (-2.73%)
Jun 18, 2026, 4:08 PM HKT
Sinopharm Group Stock Forecast
Stock Price Forecast
According to 13 analysts polled by S&P Global, Sinopharm Group stock has a consensus rating of "Buy" and an average price target of $23.12. The average 1-year stock price forecast is 41.15% higher than the current stock price, while the lowest is $17.18 (+4.88%) and the highest is $27.50 (+67.89%).
Price Target: $23.12 (+41.15%)
Analyst Consensus: Buy
* Price targets were last updated on May 14, 2026.
Analyst Ratings
The average analyst rating for Sinopharm Group stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 6 | 6 | 5 | 6 | 6 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 6 | 6 | 6 | 5 | 4 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 16 | 16 | 14 | 14 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Morgan Stanley No rating | Morgan Stanley | Buy Maintains $23.00 | Buy | Maintains | $23.00 | +40.42% | May 14, 2026 |
Unknown Analyst CLSA No rating | CLSA | Buy Maintains $25.00 | Buy | Maintains | $25.00 | +52.63% | Apr 29, 2026 |
Unknown Analyst CICC No rating | CICC | Buy Maintains $24.70 | Buy | Maintains | $24.70 | +50.79% | Apr 28, 2026 |
Unknown Analyst UOB Kay Hian No rating | UOB Kay Hian | Hold Maintains $17.00 | Hold | Maintains | $17.00 | +3.79% | Apr 28, 2026 |
Unknown Analyst First Shanghai Securities No rating | First Shanghai Securities | Buy Maintains $26.70 | Buy | Maintains | $26.70 | +63.00% | Apr 5, 2026 |
Financial Forecast
Revenue This Year
590.62B
from 575.17B
Increased by 2.69%
Revenue Next Year
622.55B
from 590.62B
Increased by 5.41%
EPS This Year
2.47
from 2.29
Increased by 7.91%
EPS Next Year
2.68
from 2.47
Increased by 8.54%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 603.6B | ||
| Avg | 590.6B | ||
| Low | 575.8B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 4.9% | ||
| Avg | 2.7% | ||
| Low | 0.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 2.47 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 7.9% | ||
| Low | - |